- Type / Class
- Equity / Common Stock
- Shares outstanding
- 53,160,953
- Total 13F shares
- 2,761,631
- Share change
- +427,746
- Total reported value
- $17,215,534
- Price per share
- $6.23
- Number of holders
- 42
- Value change
- +$2,655,569
- Number of buys
- 28
- Number of sells
- 8
Quarterly Holders Quick Answers
What is CUSIP 00973N102?
CUSIP 00973N102 identifies AKTSQ - AKTIS ONCOLOGY, INC. - Common Stock in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 00973N102:
Top shareholders of AKTSQ - AKTIS ONCOLOGY, INC. - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| HERALD INVESTMENT MANAGEMENT Ltd |
13F
|
Company |
0.97%
|
515,000
|
$3,352,000 | — | 30 Sep 2017 | |
| VANGUARD GROUP INC |
13F
|
Company |
0.76%
|
404,705
|
$2,639,000 | — | 30 Sep 2017 | |
| BlackRock Finance, Inc. |
13F
|
Company |
0.72%
|
381,945
|
$2,491,000 | — | 30 Sep 2017 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
0.28%
|
150,714
|
$983,000 | — | 30 Sep 2017 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.19%
|
99,572
|
$649,000 | — | 30 Sep 2017 | |
| STATE STREET CORP |
13F
|
Company |
0.15%
|
82,197
|
$536,000 | — | 30 Sep 2017 | |
| D.A. DAVIDSON & CO. |
13F
|
Company |
0.15%
|
79,000
|
$515,000 | — | 30 Sep 2017 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.13%
|
69,185
|
$451,000 | — | 30 Sep 2017 | |
| PRECEPT MANAGEMENT LLC |
13F
|
Company |
0.11%
|
60,000
|
$391,000 | — | 30 Sep 2017 | |
| WELLS FARGO & COMPANY/MN |
13F
|
Company |
0.07%
|
35,332
|
$230,000 | — | 30 Sep 2017 | |
| MORGAN STANLEY |
13F
|
Company |
0.05%
|
27,036
|
$177,000 | — | 30 Sep 2017 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.05%
|
26,049
|
$170,000 | — | 30 Sep 2017 | |
| TIAA CREF INVESTMENT MANAGEMENT LLC |
13F
|
Company |
0.05%
|
25,158
|
$164,000 | — | 30 Sep 2017 | |
| Commonwealth Equity Services, Inc |
13F
|
Company |
0.04%
|
23,025
|
$150,000 | — | 30 Sep 2017 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.04%
|
21,100
|
$138,000 | — | 30 Sep 2017 | |
| Parsec Financial Management, Inc. |
13F
|
Company |
0.04%
|
19,500
|
$127,000 | — | 30 Sep 2017 | |
| IHT Wealth Management, LLC |
13F
|
Company |
0.03%
|
15,281
|
$103,000 | — | 30 Sep 2017 | |
| CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM |
13F
|
Company |
0.03%
|
14,300
|
$93,000 | — | 30 Sep 2017 | |
| TEACHERS ADVISORS, LLC |
13F
|
Company |
0.02%
|
10,319
|
$67,000 | — | 30 Sep 2017 | |
| UBS Group AG |
13F
|
Company |
0.02%
|
9,307
|
$61,000 | — | 30 Sep 2017 | |
| DEUTSCHE BANK AG\ |
13F
|
Company |
0.02%
|
7,993
|
$51,000 | — | 30 Sep 2017 | |
| AMERICAN INTERNATIONAL GROUP, INC. |
13F
|
Company |
0.01%
|
5,819
|
$38,000 | — | 30 Sep 2017 | |
| Nationwide Fund Advisors |
13F
|
Company |
0.01%
|
4,665
|
$30,000 | — | 30 Sep 2017 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0%
|
2,427
|
$16,000 | — | 30 Sep 2017 | |
| Tower Research Capital LLC (TRC) |
13F
|
Company |
0%
|
2,010
|
$13,000 | — | 30 Sep 2017 | |
| Legal & General Group Plc |
13F
|
Company |
0%
|
1,284
|
$8,000 | — | 30 Sep 2017 | |
| RBC Europe Ltd |
13F
|
Company |
0%
|
1,224
|
$7,980 | — | 30 Sep 2017 | |
| BNP PARIBAS FINANCIAL MARKETS |
13F
|
Company |
0%
|
847
|
$5,522 | — | 30 Sep 2017 | |
| ROYAL BANK OF CANADA |
13F
|
Company |
0%
|
776
|
$5,000 | — | 30 Sep 2017 | |
| Ameritas Investment Partners, Inc. |
13F
|
Company |
0%
|
762
|
$5,000 | — | 30 Sep 2017 | |
| BARCLAYS PLC |
13F
|
Company |
0%
|
355
|
$2,000 | — | 30 Sep 2017 | |
| Advisory Services Network, LLC |
13F
|
Company |
0%
|
250
|
$2,000 | — | 30 Sep 2017 | |
| NEW YORK STATE COMMON RETIREMENT FUND |
13F
|
Company |
0%
|
200
|
$1,000 | — | 30 Sep 2017 |
Institutional Holders of AKTIS ONCOLOGY, INC. - Common Stock (AKTSQ) as of Q4 2017
As of 31 Dec 2017,
AKTIS ONCOLOGY, INC. - Common Stock (AKTSQ) was held by
42 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
2,761,631 shares.
The largest 10 holders included
Herald Investment Management Ltd, Vanguard Group Inc, BlackRock Inc., Precept Management LLC, Financial Advocates Investment Management, MILLENNIUM MANAGEMENT LLC, STATE STREET CORP, NORTHERN TRUST CORP, D.A. DAVIDSON & CO., and GEODE CAPITAL MANAGEMENT, LLC.
This page lists
42
institutional shareholders reporting positions in this security
for the Q4 2017 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q4 2017 vs Q3 2017 Across Filers
Q3 2017 holders
33
Q4 2017 holders
42
Holder diff
9
| Investor | Q3 2017 Shares | Q4 2017 Shares | Share Diff | Share Chg % | Q3 2017 Value $ | Q4 2017 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.